Abstract
Introduction and hypothesis: On April 16, 2019, the United States Food and Drug Administration announced a withdrawal on sales and distribution of transvaginal mesh products for pelvic organ prolapse. The aim of this study was to asses online user behavior on pelvic-mesh related articles after the withdrawal and to evaluate article accuracy.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 375-379 |
| Number of pages | 5 |
| Journal | International Urogynecology Journal |
| Volume | 32 |
| Issue number | 2 |
| DOIs | |
| State | Published - Feb 2021 |
Keywords
- FDA mesh
- Pelvic organ prolapse
- Transvaginal mesh
- Vaginal mesh
ASJC Scopus subject areas
- Obstetrics and Gynecology
- Urology
Fingerprint
Dive into the research topics of 'Media coverage of the 2019 United States Food and Drug Administration ordered withdrawal of vaginal mesh products for pelvic organ prolapse'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS